Filter
48
Featured
Recommendations
1
Language
Document type
Studies & Reports
21
Resource Platforms
6
Brochures
5
Fact sheets
4
Guidelines
3
Infographics
2
No document type
2
Manuals
1
Training Material
1
Dashboards/Maps
1
Online Courses
1
Strategic & Response Plan
1
Countries / Regions
Global
8
Africa
3
Malawi
2
India
1
Tanzania
1
Asia
1
Authors & Publishers
Publication Years
Category
Non-communicable Diseases
4
Public Health
3
Capacity Building
2
Drugs & Medical Equipment
2
Information, Education and Communication (IEC)
2
Studies & Reports
2
Malaria
2
Pharmacy & Technologies
2
Diabetes
1
Planetary Health
1
Community Health
1
Policies & Guidelines HIV & TB
1
Community Health
1
Statistics
1
Women & Child Health
1
Disease Prevention & Control
1
Key Resources
1
Toolboxes
Drug Abuse
15
Alcohol Consumption
7
Drug Resistance
7
Substance Use Disorders & Addiction
5
Alcohol
5
Essential Medecines & Medical Devices
4
Opoids
2
Studies & Reports
2
Resource Platform
2
Chemoprevention/preventive Treatment
2
Drugs
1
Cannabis
1
Attention deficit hyperactivity disorder (ADHD)
1
Postexposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)
1
HIV and coinfection
1
International
1
Pharmacovigilance
1
Capacity Building & Resources
1
Statistics & Facts
1
Clinical Aspects & Diagnosis
1
Capacity Building & Resources
1
Roadmaps, Action Plans & Strategies
1
Clinical Guidelines
1
Malaria and co-infection
1
Capacity Building & Resources
1
Online Courses & Webinars
1
Epidemiology
1
African Region
1
ART Drug Resistance, treatment failure
1
Estimated annual number of deaths from drug use disorders per 100,000 people.
EXPERT OPINION ON DRUG SAFETY 2018, VOL. 17, NO. 11, 1129–1144.
Malaria during and after pregnancy contributes significantly to maternal mortality and adverse fetal outcomes. While effective and safe antimalarial treatments are essential, quinine — an older, less effective drug — has long bee
...
To mark the International Day of the African Child, Medicines for Malaria Venture (MMV) celebrated the inclusion of three of its antimalarial medicines on the WHO Model List of Essential Medicines (EML) and the EML for Children (EMLc). These are two artemisinin-based combination therapies (ACTs) for
...
Cardiovascular diseases (CVD) represent the highest burden of disease globally. Medicines are a critical intervention used to prevent and treat CVD. This review describes access to medication for CVD from a health system perspective and strategies that have been used to promote access, including pro
...
Background
The core clinical symptoms of addiction include an enhanced incentive for drug taking (craving), impaired self-control (impulsivity and compulsivity), emotional dysregulation (negative mood) and increased stress reactivity. Symptoms related to impaired self-control involve reduced activi
...
Since the 1960s, the Tanzanian government has been striving to improve access to quality healthcare, including primary care. However, tuberculosis (TB) remains a significant public health concern, with an estimated prevalence rate of 528 cases per 100,000 people. However, currently, only 36% of TB c
...
Antimalarial chemotherapy is crucial for reducing morbidity, mortality, and drug resistance, and is the cornerstone of malaria control. Existing antimalarial drugs act at different stages of the parasite’s life cycle. These drugs range from classic agents such as chloroquine and quinine to newer a
...
Combination therapy is a cornerstone of modern malaria treatment, particularly in the context of widespread multidrug resistance. Using two or more antimalarial drugs with different mechanisms simultaneously enhances efficacy, shortens treatment duration, improves compliance and delays the developme
...
